Table 2 PD cohort Metabolic Syndrome components.

From: Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease

 

iPD

LRRK2-PD

GBA-PD

significance

#

104

40

70

 

HDL (mg/Dl)

56.20 (16.24)

62.02 (19.36)

54.24 (16.35)

0.073

Triglycerides (mg/Dl)

117.24 (57.96)

158.10 (100.48) @

130.90 (60.60)

0.015*

HbA1c (%)

5.65 (0.54)

5.82 (0.51)

5.61 (0.59)

0.108

BMI (kg/m2)

25.58 (3.08)

25.77 (3.96)

26.03 (4.16)

0.725

Hypo-HDL (%)

20.00%

7.50%

20.80%

0.160

Hypertriglyceridemia (%)

41.90%

52.50%

38.90%

0.364

Prediabetes (%)

34.30%

65.00%@

43.10%

0.004*

Hypertension (%)

75.20%

80.00%

79.20%

0.754

Obesity (BMI > 30) (%)

9.50%

15.00%

19.40%

0.167

  1. iPD – idiopathic Parkinson’s Disease, HDL- High Density Lipoprotein, HbA1c – Hemoglobin A1C, BMI- Body Mass Index. *Significant after correcting for multiple comparisons with Bonferroni adjustment.
  2. @Differences between LRRK2-PD and GBA-PD, iPD.
Back to article page